(Q51559638)

7 April 2018

title

Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age. (English)

1 reference

7 April 2018

author

Walter E Haefeli

6

1 reference

7 April 2018

author name string

Todesco L

1

1 reference

7 April 2018

Angst C

2

1 reference

7 April 2018

Litynski P

3

1 reference

7 April 2018

Loehrer F

4

1 reference

7 April 2018

Fowler B

5

1 reference

7 April 2018

publication date

1 December 1999

1 reference

7 April 2018

European Journal of Clinical Investigation

published in

1 reference

7 April 2018

volume

29

1 reference

7 April 2018

page(s)

1003-1009

1 reference

7 April 2018

issue

12

1 reference

7 April 2018

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Homocysteinemia due to folate deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

The effect of a subnormal vitamin B-6 status on homocysteine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Heterozygous missense mutation in the rod cGMP phosphodiesterase beta-subunit gene in autosomal dominant stationary night blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Congenital non-progressive encephalopathy and deafness with intermittent episodes of coma and hyperkynureninuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Plasma homocyst(e)ine levels in men with premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00578.X

10.1046/J.1365-2362.1999.00578.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

10583447

1 reference

7 April 2018